Clinical Trials Browser

INDUSTRY × radium Ra 223 dichloride × 90 days × Clear all

NCT07611110 2026-05-28

VECTRA-01

Phase 3 Recruiting

Prostatic Neoplasms

NCT04597125 2026-05-11

RADIANT: A Study of Radium-223 Dichloride (Xofigo) vs Enzalutamide or Abiraterone (ARPIs, Androgen Receptor Pathway Inhibitors) in Patients With Prostate Cancer That Has Spread to the Bones (mCRPC, Metastatic Castration-Resistant Prostate Cancer)

Phase 4 Active not recruiting

Metastatic Castrate Resistant Prostate Cancer (mCRPC)